Johnson & Johnson - 34 Year Dividend History | JNJ

Historical dividend payout and yield for Johnson & Johnson (JNJ) since 1991. The current TTM dividend payout for Johnson & Johnson (JNJ) as of May 30, 2025 is $5.20. The current dividend yield for Johnson & Johnson as of May 30, 2025 is 3.39%.
Sector Industry Market Cap Revenue
Medical Large Cap Pharmaceutical $369.525B $88.821B
Johnson & Johnson's biggest strength is its diversified business model. It operates through pharmaceuticals, medical devices and consumer products divisions. Its diversification helps it to withstand economic cycles more effectively. J&J has one of the largest research and development (R&D) budget among pharma companies. J&J's worldwide business is divided into three segments: Pharmaceutical, Medical Devices and Consumer. The company has several drugs covering a broad range of areas such as neuroscience, cardiovascular & metabolism, immunology, oncology, pulmonary hypertension and infectious diseases and vaccines. The Medical Devices Segment offers products in the orthopedics, surgery, interventional solutions and vision markets. The Consumer Segment segment includes a broad range of products covering the areas of baby care, beauty/skin health, oral care, wound care and womens' health care, as well as over-the-counter (OTC) pharmaceutical products.
Stock Name Country Market Cap PE Ratio
Eli Lilly (LLY) United States $684.805B 52.51
AbbVie (ABBV) United States $327.880B 18.07
Novo Nordisk (NVO) Denmark $311.704B 20.55
Roche Holding AG (RHHBY) Switzerland $252.088B 0.00
Novartis AG (NVS) Switzerland $237.816B 13.58
Merck (MRK) United States $191.843B 9.81
Pfizer (PFE) United States $133.322B 7.31
Sanofi (SNY) France $128.386B 12.65
Bayer (BAYRY) Germany $27.744B 5.65
Innoviva (INVA) United States $1.223B 12.82